References
Abay GK, Abraha BH. Trends of Mycobacterium tuberculosis and rifampicin
resistance in Adigrat General Hospital, Eastern zone of Tigrai, North
Ethiopia. Trop Dis Travel Med Vaccines. 2020;6:14.
Abdella K, Abdissa K, Kebede W, Abebe G. Drug resistance patterns of
Mycobacterium tuberculosis complex and associated factors among
retreatment cases around Jimma, Southwest Ethiopia. BMC Public Health.
2015;15:599.
Adane K, Ameni G, Bekele S, Abebe M, Aseffa A. Prevalence and drug
resistance profile of Mycobacterium tuberculosis isolated from pulmonary
tuberculosis patients attending two public hospitals in East Gojjam
zone, northwest Ethiopia. BMC Public Health. 2015;15:572.
Alene KA, Viney K, McBryde ES, Gray DJ, Melku M, Clements ACA. Risk
factors for multidrug-resistant tuberculosis in northwest Ethiopia: A
case-control study. Transbound Emerg Dis. 2019;66(4):1611-8.
Arega B, Menbere F, Getachew Y. Prevalence of rifampicin resistant
Mycobacterium tuberculosis among presumptive tuberculosis patients in
selected governmental hospitals in Addis Ababa, Ethiopia. BMC infectious
diseases. 2019;19(1):307.
Assefa D, Seyoum B, Oljira L. Determinants of multidrug-resistant
tuberculosis in Addis Ababa, Ethiopia. Infect Drug Resist.
2017;10:209-13.
Babure ZK, Bidu KT, Assefa JF, Weldemarium TD, Tufa AF. Risk factors for
MDR-TB among Tuberculosis patients of Nekemte Referral Hospital Oromia
Regional State, Westernn Ethiopia, 2017. IJBAF. 2019, 7(4): 63-77
Bedewi Z, Mekonnen Y, Worku A, Medhin G, Zewde A, Yimer G, et al.
Mycobacterium tuberculosis in central Ethiopia: drug sensitivity
patterns and association with genotype. New Microbes New Infect.
2017;17:69-74.
Biru D, Woldesemayat EM. Determinants of Drug-Resistant Tuberculosis in
Southern Ethiopia: A Case-Control Study. Infect Drug Resist.
2020;13:1823-9.
Deressa MA, Demissie M. Risk Factors of Multi-Drug Resistant
Tuberculosis in Addis Ababa, Ethiopia: A Matched Case-Control Study.
OALib. 2014;01(03):1-8.
Desissa F, Workineh T, Beyene T. Risk factors for the occurrence of
multidrug-resistant tuberculosis among patients undergoing
multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia. BMC
Public Health. 2018;18(1):422.
Dessalegn M, Daniel E, Behailu S, Wagnew M, Nyagero J. Predictors of
multidrug resistant tuberculosis among adult patients at Saint Peter
Hospital Addis Ababa, Ethiopia. Pan Afr Med J. 2016;25(Suppl 2):5.
Diande´ S, Sangare´ L, Kouanda S, Dingtoumda BI, Mourfou A, et al. Risk
Factors for Multidrug-Resistant Tuberculosis in Four Centers in Burkina
Faso, West Africa. Microbial Drug Resistance. 2009; 15(3).
Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant
tuberculosis in Europe: a systematic review. Thorax. 2006;61(2):158-63.
Fikre A, Tewelde T, Shaweno T. Determinants of Multi-Drug Resistant
Tuberculosis among Tuberculosis Patients in Southern Ethiopia: A Case
Control Study. J Med Bacteriol. 2019; 8 (1): 1-12.
Flora MS, Amin MN, Karim MR, Afroz S3, Islam S, Alam A, Hossain M. Risk
factors of multi-drug-resistant tuberculosis in Bangladeshi population:
a case control study. Bangladesh Med Res Counc Bull. 2013; 39: 34-41.
Gobena D, Ameya G, Haile K, Abreha G, Worku Y, Debela T. Predictor of
multidrug resistant tuberculosis in southwestern part of Ethiopia: a
case control study. Ann Clin Microbiol Antimicrob. 2018;17(1):30.
Hamusse SD, Teshome D, Hussen MS, Demissie M, Lindtjorn B. Primary and
secondary anti-tuberculosis drug resistance in Hitossa District of Arsi
Zone, Oromia Regional State, Central Ethiopia. BMC Public Health.
2016;16:593.
Hirpa S, Medhin G, Girma B, Melese M, Mekonen A, et al. Determinants of
multidrug-resistant tuberculosis in patients who underwent first-line
treatment in Addis Ababa: a case control study. BMC Public Health.
2013;13:782
Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et
al. The PRISMA extension statement for reporting of systematic reviews
incorporating network meta-analyses of health care interventions:
checklist and explanations. Annals of internal medicine.
2015;162(11):777-84.
Jaleta KN, Gizachew M, Gelaw B, Tesfa H, Getaneh A, Biadgo B.
Rifampicin-resistant Mycobacterium tuberculosis among
tuberculosis-presumptive cases at University of Gondar Hospital,
northwest Ethiopia. Infect Drug Resist. 2017;10:185-92.
Jimma W, Ghazisaeedi M, Shahmoradi L, Abdurahman AA, Kalhori SRN, Nasehi
M, et al. Prevalence of and risk factors for multidrug-resistant
tuberculosis in Iran and its neighboring countries: systematic review
and meta-analysis. Rev Soc Bras Med Trop. 2017;50(3):287-95.
Knobloch K, Yoon U, Vogt PM. Preferred reporting items for systematic
reviews and meta-analyses (PRISMA) statement and publication bias. J
Craniomaxillofac Surg. 2011;39(2):91-2.
Li WB, Zhang YQ, Xing J, Ma ZY, Qu YH, Li XX. Factors associated with
primary transmission of multidrug-resistant tuberculosis compared with
healthy controls in Henan Province, China. Infectious diseases of
poverty. 2015;4:14.
Liu Q, Zhu L, Shao Y, Song H, Li G, et al. Rates and risk factors for
drug resistance tuberculosis in Northeastern China. BMC Public Health.
2013; 13:1171.
Lomtadze N, Aspindzelashvili R, Janjgava M, Mirtskhulava V, Wright A, et
al. . Prevalence and Risk Factors for Multidrug-Resistant Tuberculosis
in Republic of Georgia: A Population Based Study. Int J Tuberc Lung Dis.
2009; 13(1): 68–73.
Lukoye D, Ssengooba W, Musisi K, Kasule GW, Cobelens FG, Joloba M, et
al. Variation and risk factors of drug resistant tuberculosis in
sub-Saharan Africa: a systematic review and meta-analysis. BMC Public
Health. 2015;15:291.
Mehari K, Asmelash T, Hailekiros H, Wubayehu T, Godefay H, Araya T, et
al. Prevalence and Factors Associated with Multidrug-Resistant
Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray
Region, Northern Ethiopia. Can J Infect Dis Med Microbiol.
2019;2019:2923549.
Mekonnen F, Tessema B, Moges F, Gelaw A, Eshetie S, Kumera G. Multidrug
resistant tuberculosis: prevalence and risk factors in districts of
metema and west armachiho, Northwest Ethiopia. BMC infectious diseases.
2015;15:461.
Mesfin EA, Beyene D, Tesfaye A, Admasu A, Addise D, Amare M, et al.
Drug-resistance patterns of Mycobacterium tuberculosis strains and
associated risk factors among multi drug-resistant tuberculosis
suspected patients from Ethiopia. PloS one. 2018;13(6):e0197737.
Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M,
Qureshi R, Mattis P, Lisy K, Mu 370 P-F. Chapter 7: Systematic reviews
of etiology and risk. In: Aromataris E, Munn Z (Editors). JBI Manual for
371 Evidence Synthesis. JBI, 2020. Available from
https://synthesismanual.jbi.global.
Mulisa G, Workneh T, Hordofa N, Suaudi M, Abebe G, Jarso G.
Multidrug-resistant Mycobacterium tuberculosis and associated risk
factors in Oromia Region of Ethiopia. Int J Infect Dis. 2015;39:57-61.
Mulu W, Mekonnen D, Yimer M, Admassu A, Abera B. Risk factors for
multidrug resistant tuberculosis patients in Amhara National Regional
State. Afr Health Sci. 2015;15(2):368-77.
Munn Z, Aromataris E, Tufanaru C, Stern C, Porritt K, Farrow J, et al.
The development of software to support multiple systematic review types:
the Joanna Briggs Institute System for the Unified Management,
Assessment and Review of Information (JBI SUMARI). Int J Evid Based
Healthc. 2019;17(1):36-43.
Pang Y, An J, Shu W, Huo F, Chu N, Gao M, et al. Epidemiology of
Extrapulmonary Tuberculosis among Inpatients, China, 2008-2017. Emerg
Infect Dis. 2019;25(3):457-64.
Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology
of extrapulmonary tuberculosis in the United States, 1993-2006. Clin
Infect Dis. 2009;49(9):1350-7.
Petrini B, Hoffner S. Drug-resistant and multidrug-resistant tubercle
bacilli. International Journal of Antimicrobial Agents. 1999; 13:
93–97.
Porritt K, Gomersall J, Lockwood C. JBI’s systematic reviews: study
selection and critical appraisal. Am J Nurs. 2014;114(6):47–52.
Pradipta IS, Forsman LD, Bruchfeld J, Hak E, Alffenaar JW. Risk factors
of multidrug-resistant tuberculosis: A global systematic review and
meta-analysis. J Infect. 2018;77(6):469-78.
Przybylski G, Dabrowska A, Pilaczynska-Cemel M, Krawiecka D.
Unemployment in TB patients - ten-year observation at regional center of
pulmonology in Bydgoszcz, Poland. Med Sci Monit. 2014;20:2125-31.
Raveendran R, Oberoi JK, Wattal C. Multidrug-resistant pulmonary &
extrapulmonary tuberculosis: A 13 years retrospective hospital-based
analysis. Indian J Med Res. 2015;142(5):575-82.
Riley RD, Higgins JPT, Deek JJ. Interpretation of random effects
meta-analyses. BMJ.2011; 342:dS49
Seyoum B, Demissie M, Worku A, Bekele S, Aseffa A. Prevalence and Drug
Resistance Patterns of Mycobacterium tuberculosis among New Smear
Positive Pulmonary Tuberculosis Patients in Eastern Ethiopia. Tuberc Res
Treat. 2014;2014:753492.
Shivekar SS, Kaliaperumal V, Brammacharry U, Sakkaravarthy A, Raj CKV,
Alagappan C, et al. Prevalence and factors associated with
multidrug-resistant tuberculosis in South India. Sci Rep.
2020;10(1):17552.
Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis:
guidelines on choice of axis. J Clin Epidemiol. 2001; 54(10):1046–55.
Tadesse F. Risk Factors for Multi-drug Resistant Tuberculosis in Addis
Ababa, Ethiopia. Universal Journal of Public Health. 2015;3(2):65-70.
Tesfay K, Tesfay S, Nigus E, Gebreyesus A, Gebreegziabiher D, Adane K.
More than half of presumptive multidrug-resistant cases referred to a
tuberculosis referral laboratory in the Tigray region of Ethiopia are
multidrug resistant. Int J Mycobacteriol. 2016;5(3):324-7.
Tsega T, Gedle D, Dilnessa T. Prevalence of Multidrug Resistant
Tuberculosis and its Associated Factors among Smear Positive TB Patients
at Debre Markos Referral Hospital, Northwest Ethiopia. Global Journal of
Medical Research: C Microbiology and Pathology. 2017; 17(2).
Welekidan LN, Skjerve E, Dejene TA, Gebremichael MW, Brynildsrud O,
Agdestein A, et al. Characteristics of pulmonary multidrug-resistant
tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional
study. PloS one. 2020;15(8):e0236362.
WHO. Recommendations for investigating contacts of persons with
infectious tuberculosis in low- and middle-income countries. World
Health Organization; 2012.
WHO. Global tuberculosis report. Geneva, Switzerland: World Health
Organization; 2019.
WHO. Global tuberculosis report. Geneva, Switzerland: World Health
Organization; 2020.
Zhao P, Li X, Zhang S, Wang X, Liu C. Social Behaviour Risk Factors for
Drug Resistant Tuberculosis in Mainland China: a Meta-analysis. The
Journal of International Medical Research 2012; 40: 436 – 445.
Table 1: Characteristics of individual studies on the
determinants of drug-resistant tuberculosis in Ethiopia, included in
this systematic review and meta-analysis.